Jun 12, 2020
EHA25Virtual: Ruxolitinib, the First Proven Drug for Treating Steroid-refractory Acute GVHD
Jun 11, 2020
Partner Therapeutics Announces Initiation of Clinical Trial Evaluating Leukine® in T Cell Replete HLA-mismatched Haploidentical Stem Cell Transplant
May 18, 2020
Cellect Biotechnology's ApoGraft(TM) to Empower Cellular Treatment of COVID-19 Related Pulmonary Diseases
May 11, 2020
Pipeline Product Launches for Graft vs Host Disease to 2025
Apr 27, 2020
Graft Versus Host Disease (GvHD) Pipeline Guide, H1 2020
Apr 24, 2020
Graft Versus Host Disease (GvHD) Prophylaxis and Treatment Landscape Assessment 2018-2028
Dec 10, 2019
Syndax Pharmaceuticals Announces Plans to Commence Phase 2 Expansion Cohort of SNDX-6352 for the Treatment of Chronic Graft Versus Host Disease
Oct 31, 2019
Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults
Jul 08, 2019
Cellect Biotechnology and Washington University (WU) Finalize Accelerated Clinical Trial Agreement
Mar 29, 2019
Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director
Mar 26, 2019
Mallinckrodt Announces 2019 Investigator Award for Pioneering Efforts in ECP Immunomodulation
Feb 19, 2019
Americord announces five-compartment bags and best-in-industry quality guarantee
Feb 05, 2019
Cellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellect's ApoGraft(TM) for Bone Marrow Transplantations
Dec 18, 2018
Global Transplant Complications Drug Development Pipeline Review 2018 Featuring Medeor Therapeutics, Amgen and Novartis
Dec 01, 2018
Studies Show Improved Sickle Cell Disease Outcomes Worldwide
Oct 15, 2018
Cellect Announces Positive Clinical Results
Aug 20, 2018
NYU Langone's Blood & Marrow Transplant Program Expands Services
Aug 08, 2018
Viracor Eurofins' Algorithms Predict Risk of aGVHD and Non-relapse Mortality in Allogeneic HCT Patients
Aug 07, 2018
Cellect Granted Key European Patent for Its Stem Cell Selection Technology
Jul 05, 2018
Neovii & Mundipharma Confirm In-licensing Agreement for the Development and Promotion of Grafalon(R) in China and Japan for Solid Organ & Stem Cell Transplant